MCM2 and hepatocellular carcinoma: Taken together, the results of the present study demonstrated that CDC14B, CDC20, CDK1, MCM2, MCM6, and MCM7 may be potential diagnostic biomarkers and BUB3, CDK1, and CHEK1 may serve as a negative prognostic biomarker for HCC patients.